Bruner, Katherine M.
Wang, Zheng
Simonetti, Francesco R.
Bender, Alexandra M.
Kwon, Kyungyoon J.
Sengupta, Srona
Fray, Emily J.
Beg, Subul A.
Antar, Annukka A. R.
Jenike, Katharine M.
Bertagnolli, Lynn N.
Capoferri, Adam A.
Kufera, Joshua T.
Timmons, Andrew
Nobles, Christopher
Gregg, John
Wada, Nikolas
Ho, Ya-Chi
Zhang, Hao
Margolick, Joseph B.
Blankson, Joel N.
Deeks, Steven G.
Bushman, Frederic D.
Siliciano, Janet D.
Laird, Gregory M.
Siliciano, Robert F.
Article History
Received: 19 April 2018
Accepted: 4 January 2019
First Online: 30 January 2019
Competing interests
: Aspects of IPDA are subject of a patent application PCT/US16/28822 filed by Johns Hopkins University. K.M.B. and R.F.S. are inventors on this application. Accelevir Diagnostics holds an exclusive license for this patent application. G.M.L. is an employee of and shareholder in Accelevir Diagnostics. R.F.S. holds no equity interest in Accelevir Diagnostics. R.F.S. is a consultant on cure-related HIV research for Merck and Abbvie.